Open Access Open Access  Restricted Access Subscription or Fee Access

Comparison of ependymomas and medulloblastomas located in the posterior cranial fossa: An anatomical and histopathological study

T. Yilmaz, P. Aydin Özturk, Y. Turan, I. Başar, B. Aslanoğlu, K. Aydin, İ. İbiloğlu, Mehmet Cudi Tuncer


Posterior fossa tumors (PFTs) include medulloblastomas, atypical teratoid/rhabdoid tumors, pilocytic astrocytomas, ependymomas, and brainstem gliomas. We evaluated patients with surgery at our clinic, comparing epidemiological, clinical, radiological, and pathological characteristics of medulloblastoma and ependymoma to identify factors that might assist preoperative diagnosis, help to develop treatment algorithms, and have prognostic value after surgery. Pediatric patients from 0 to 16 and young adults from 16 to 29 years of age with surgery for pathologically confirmed ependymomas or medulloblastomas between January 2014 and January 2020 were eligible. The study included 19 patients, seven with ependymoma (37%) and 12 with medulloblastoma (63.2%). The ependymoma patients were 5.29 ± 5.85 years of age, the medulloblastoma patients were 11.58 ± 8.17 years of age, and 16 patients (84%) were children.Fifteen patients (79%) presented with signs of increased intracranial pressure and four (21%) presented with cerebellar findings. MRI found that 74% (14) of the PSTs were located in the midline, including six of the seven ependymomas (86%) and eight of the 12 medulloblastomas (67%). Enhancement was significantly greater in medulloblastomas compared with ependymomas (p = 0.022). In according to pathology results; synaptophysin, NSE, chromogranin and 50% GFAP positivity were observed in medulloblastoma. Ependymomas were S100 (43%) and vimentin (29%) positive. Ependymoma patients were younger than medulloblastoma patients and more were female. There were no significant differences in the clinical findings, but ependymomas were larger and had greater rates of enhancement and spinal metastasis compared with medulloblastomas.


Posterior cranial fossa tumors, Epithelial Membrane Antigen/EMA, Ki-67, MRI.

Full Text:



Di Rosa M, Sanfilippo C, Libra M, Musumeci G, Malaguarnera L (2015) Different pediatric brain tumors are associated with different gene expression profiling. Acta Histochem 117(4-5):477-85. doi: 10.1016/j.acthis.2015.02.010.

Quinlan A, Rizzolo D (2017) Understanding medulloblastoma. JAAPA 30(10):30-36. doi: 10.1097/01.JAA.0000524717.71084.50.

Brandão LA, Young Poussaint T (2017) Posterior Fossa Tumors. Neuroimaging Clin N Am 27(1):1-37. doi: 10.1016/j.nic.2016.08.001.

Millard NE, De Braganca KC (2016) Medulloblastoma J Child Neurol 31(12):1341-53. doi: 10.1177/0883073815600866.

Archer TC, Mahoney EL, Pomeroy SL (2017) Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics 14(2):265-273. doi: 10.1007/s13311-017-0526-y.

Neumann JE, Spohn M, Obrecht D, Mynarek M, Thomas C, Hasselblatt M, et al (2020) Molecular characterization of histopathological ependymoma variants. Acta Neuropathol 139(2):305-318. doi: 10.1007/s00401-019-02090-0.

Evenson M, Cai C, Hucthagowder V, McNulty S, Neidich J, Kulkarni S, et al (2020) Utility of copy number variants in the classification of intracranial ependymoma. Cancer Genet 240:66-72. doi: 10.1016/j.cancergen.2019.11.003.

Bahmad HF, Poppiti RJ (2020) Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets. J Clin Pathol 73(5):243-249. doi: 10.1136/jclinpath-2019-206246.

Pollack IF, Agnihotri S, Broniscer A (2019) Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr 23(3):261-273. doi: 10.3171/2018.10.PEDS18377.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803-20. doi: 10.1007/s00401-016-1545-1.

Thompson YY, Ramaswamy V, Diamandis P, Daniels C, Taylor MD (2015) Posterior fossa ependymoma: current insights. Childs Nerv Syst 31(10):1699-706. doi: 10.1007/s00381-015-2823-2.

Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, et al (2019) EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol 20(12):e715-e728. doi: 10.1016/S1470-2045(19)30669-2.

Jünger ST, Mynarek M, Wohlers I, Dörner E, Mühlen AZ, Velez-Char N, et al (2019) Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort. Acta Neuropathol Commun 7(1):181. doi: 10.1186/s40478-019-0820-5.

Pierscianek D, Teuber-Hanselmann S, Ahmadipour Y, Darkwah Oppong M, Unteroberdörster M, Müller O, et al (2020) TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma. Neuropathology 40(2):138-143. doi: 10.1111/neup.12615.

Duc NM, Huy HQ (2019) Magnetic Resonance Imaging Features of Common Posterior Fossa Brain Tumors in Children: A Preliminary Vietnamese Study. Open Access Maced J Med Sci 7(15):2413-2418. doi: 10.3889/oamjms.2019.635.

Vinchon M, Leblond P (2019) Medulloblastoma: Clinical presentation. Neurochirurgie S0028-3770(19)30208-5. doi: 10.1016/j.neuchi.2019.04.006.

Han Z, Kang P, Zhang H, Liao Z, Li C, Gong J, Liu W, et al (2020) Prognostic value of H3K27me3 in children with ependymoma. Pediatr Blood Cancer 67(3):e28121. doi: 10.1002/pbc.28121.

Kombogiorgas D, Natarajan K, Sgouros S (2008) Predictive value of preoperative ventricular volume on the need for permanent hydrocephalus treatment immediately after resection of posterior fossa medulloblastomas in children. J Neurosurg Pediatr 1(6):451-5. doi: 10.3171/PED/2008/1/6/451.

D'Arcy CE, Nobre LF, Arnaldo A, Ramaswamy V, Taylor MD, Naz-Hazrati L, et al (2020) Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples. J Neuropathol Exp Neurol 79(4):437-447. doi: 10.1093/jnen/nlaa005.

Sun PF, Ma L, Ye BQ, Pei YY (2020) Application of diffusion-weighted imaging combined with apparent diffusion coefficient in differential diagnosis between central neurocytoma and ependymoma. Neuroradiology 62(4):439-445. doi: 10.1007/s00234-019-02342-6.



  • There are currently no refbacks.